Page last updated: 2024-09-02

perindopril and Local Neoplasm Recurrence

perindopril has been researched along with Local Neoplasm Recurrence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimoto, M; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Mitoro, A; Noguchi, R; Sawai, M; Toyohara, M; Tsujimoto, T; Uemura, M; Yamao, J; Yamazaki, M; Yoshida, M; Yoshiji, H1
Aihara, Y; Fujimoto, M; Fukui, H; Ikenaka, Y; Kaji, K; Mitoro, A; Morioka, C; Noguchi, R; Sawai, M; Toyohara, M; Uemura, M; Yamao, J; Yamazaki, M; Yoshida, M; Yoshiji, H1

Trials

2 trial(s) available for perindopril and Local Neoplasm Recurrence

ArticleYear
Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.
    Journal of hepatology, 2009, Volume: 51, Issue:2

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Hepatocellular; Catheter Ablation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Perindopril; Survival Rate; Vascular Endothelial Growth Factor A; Vitamin K 2

2009
Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial.
    Oncology reports, 2011, Volume: 26, Issue:6

    Topics: Aged; Amino Acids, Branched-Chain; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Humans; Insulin Resistance; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Perindopril; Treatment Outcome

2011